Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies
Identifieur interne : 002975 ( PascalFrancis/Curation ); précédent : 002974; suivant : 002976Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies
Auteurs : Peggy Reiner [France] ; Damien Galanaud [France] ; Gaëlle Leroux [France] ; Marie Vidailhet [France] ; Julien Haroche [France] ; Du Le Thi Huong [France] ; Camille Frances [France] ; Thomas Papo [France] ; Christian De Gennes [France] ; Lucile Musset [France] ; Bertrand Wechsler [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Nathalie Costedoat-Chalumeau [France]Source :
- Movement disorders [ 0885-3185 ] ; 2011.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
Objective: The aim of this work was to describe chorea during systemic lupus erythematosus or antiphospholipid antibodies and its long-term outcome. Methods: We retrospectively analyzed clinical features, laboratory findings, imaging characteristics, and outcome in a series of 32 patients. Results: Most patients were women (28 of 32), and mean age at onset of chorea was 20.6 (9-62) years. Chorea was inaugural for 28 patients. Improvement was observed with various treatments. During follow-up (12.2 ±11.3 years), severe manifestations of systemic lupus erythematosus were rare. Antiphospholipid antibodies were repeatedly positive for 90% of the patients. Twelve patients developed arterial thrombosis. Prophylactic treatment with antithrombotic therapy might reduce the risk of further thrombosis (8% versus 57%; P = 0.01). Cardiac valvulopathy occurred in 22 patients during follow-up. Chorea relapsed in 8 cases. Conclusions: Chorea had a good outcome in itself. This long-term follow-up shows, for the first time, that these patients have substantial risk for further arterial thrombosis.
pA |
|
---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000339
Links to Exploration step
Pascal:12-0026980Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies</title>
<author><name sortKey="Reiner, Peggy" sort="Reiner, Peggy" uniqKey="Reiner P" first="Peggy" last="Reiner">Peggy Reiner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, AP-HP, Hôpital Lariboisière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Galanaud, Damien" sort="Galanaud, Damien" uniqKey="Galanaud D" first="Damien" last="Galanaud">Damien Galanaud</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Service de Neuroradiologie, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Leroux, Gaelle" sort="Leroux, Gaelle" uniqKey="Leroux G" first="Gaëlle" last="Leroux">Gaëlle Leroux</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Fédération des Maladies du Système Nerveux Central, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Haroche, Julien" sort="Haroche, Julien" uniqKey="Haroche J" first="Julien" last="Haroche">Julien Haroche</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Thi Huong, Du Le" sort="Thi Huong, Du Le" uniqKey="Thi Huong D" first="Du Le" last="Thi Huong">Du Le Thi Huong</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Frances, Camille" sort="Frances, Camille" uniqKey="Frances C" first="Camille" last="Frances">Camille Frances</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Service de Dermatologie, Hôpital Tenon, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Service de Médecine Interne, AP-HP, Hôpital Bichat</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="De Gennes, Christian" sort="De Gennes, Christian" uniqKey="De Gennes C" first="Christian" last="De Gennes">Christian De Gennes</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Musset, Lucile" sort="Musset, Lucile" uniqKey="Musset L" first="Lucile" last="Musset">Lucile Musset</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Service d'Immunochimie, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Wechsler, Bertrand" sort="Wechsler, Bertrand" uniqKey="Wechsler B" first="Bertrand" last="Wechsler">Bertrand Wechsler</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Amoura, Zahir" sort="Amoura, Zahir" uniqKey="Amoura Z" first="Zahir" last="Amoura">Zahir Amoura</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Piette, Jean Charles" sort="Piette, Jean Charles" uniqKey="Piette J" first="Jean-Charles" last="Piette">Jean-Charles Piette</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Costedoat Chalumeau, Nathalie" sort="Costedoat Chalumeau, Nathalie" uniqKey="Costedoat Chalumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0026980</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 12-0026980 INIST</idno>
<idno type="RBID">Pascal:12-0026980</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000339</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002975</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies</title>
<author><name sortKey="Reiner, Peggy" sort="Reiner, Peggy" uniqKey="Reiner P" first="Peggy" last="Reiner">Peggy Reiner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Service de Neurologie, AP-HP, Hôpital Lariboisière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Galanaud, Damien" sort="Galanaud, Damien" uniqKey="Galanaud D" first="Damien" last="Galanaud">Damien Galanaud</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Service de Neuroradiologie, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Leroux, Gaelle" sort="Leroux, Gaelle" uniqKey="Leroux G" first="Gaëlle" last="Leroux">Gaëlle Leroux</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Fédération des Maladies du Système Nerveux Central, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Haroche, Julien" sort="Haroche, Julien" uniqKey="Haroche J" first="Julien" last="Haroche">Julien Haroche</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Thi Huong, Du Le" sort="Thi Huong, Du Le" uniqKey="Thi Huong D" first="Du Le" last="Thi Huong">Du Le Thi Huong</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Frances, Camille" sort="Frances, Camille" uniqKey="Frances C" first="Camille" last="Frances">Camille Frances</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Service de Dermatologie, Hôpital Tenon, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Service de Médecine Interne, AP-HP, Hôpital Bichat</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="De Gennes, Christian" sort="De Gennes, Christian" uniqKey="De Gennes C" first="Christian" last="De Gennes">Christian De Gennes</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Musset, Lucile" sort="Musset, Lucile" uniqKey="Musset L" first="Lucile" last="Musset">Lucile Musset</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Service d'Immunochimie, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Wechsler, Bertrand" sort="Wechsler, Bertrand" uniqKey="Wechsler B" first="Bertrand" last="Wechsler">Bertrand Wechsler</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Amoura, Zahir" sort="Amoura, Zahir" uniqKey="Amoura Z" first="Zahir" last="Amoura">Zahir Amoura</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Piette, Jean Charles" sort="Piette, Jean Charles" uniqKey="Piette J" first="Jean-Charles" last="Piette">Jean-Charles Piette</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Costedoat Chalumeau, Nathalie" sort="Costedoat Chalumeau, Nathalie" uniqKey="Costedoat Chalumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiphospholipid antibody syndrome</term>
<term>Chorea</term>
<term>Human</term>
<term>Long term</term>
<term>Nervous system diseases</term>
<term>Platelet</term>
<term>Prognosis</term>
<term>Systemic lupus erythematosus</term>
<term>Thrombosis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Syndrome choréique</term>
<term>Lupus érythémateux disséminé</term>
<term>Syndrome des antiphospholipides</term>
<term>Thrombose</term>
<term>Pathologie du système nerveux</term>
<term>Long terme</term>
<term>Pronostic</term>
<term>Homme</term>
<term>Thrombocyte</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective: The aim of this work was to describe chorea during systemic lupus erythematosus or antiphospholipid antibodies and its long-term outcome. Methods: We retrospectively analyzed clinical features, laboratory findings, imaging characteristics, and outcome in a series of 32 patients. Results: Most patients were women (28 of 32), and mean age at onset of chorea was 20.6 (9-62) years. Chorea was inaugural for 28 patients. Improvement was observed with various treatments. During follow-up (12.2 ±11.3 years), severe manifestations of systemic lupus erythematosus were rare. Antiphospholipid antibodies were repeatedly positive for 90% of the patients. Twelve patients developed arterial thrombosis. Prophylactic treatment with antithrombotic therapy might reduce the risk of further thrombosis (8% versus 57%; P = 0.01). Cardiac valvulopathy occurred in 22 patients during follow-up. Chorea relapsed in 8 cases. Conclusions: Chorea had a good outcome in itself. This long-term follow-up shows, for the first time, that these patients have substantial risk for further arterial thrombosis.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>26</s2>
</fA05>
<fA06><s2>13</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>REINER (Peggy)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>GALANAUD (Damien)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>LEROUX (Gaëlle)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>VIDAILHET (Marie)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>HAROCHE (Julien)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>THI HUONG (Du Le)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>FRANCES (Camille)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>PAPO (Thomas)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>DE GENNES (Christian)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MUSSET (Lucile)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>WECHSLER (Bertrand)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>AMOURA (Zahir)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>PIETTE (Jean-Charles)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>COSTEDOAT-CHALUMEAU (Nathalie)</s1>
</fA11>
<fA14 i1="01"><s1>Service de Neurologie, AP-HP, Hôpital Lariboisière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Service de Médecine Interne, Centre de Reference National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Service de Neuroradiologie, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Fédération des Maladies du Système Nerveux Central, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Service de Dermatologie, Hôpital Tenon, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Service de Médecine Interne, AP-HP, Hôpital Bichat</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Service d'Immunochimie, AP-HP, Centre Hospitalier Universitaire Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20><s1>2422-2427</s1>
</fA20>
<fA21><s1>2011</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000505925010190</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>26 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0026980</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Objective: The aim of this work was to describe chorea during systemic lupus erythematosus or antiphospholipid antibodies and its long-term outcome. Methods: We retrospectively analyzed clinical features, laboratory findings, imaging characteristics, and outcome in a series of 32 patients. Results: Most patients were women (28 of 32), and mean age at onset of chorea was 20.6 (9-62) years. Chorea was inaugural for 28 patients. Improvement was observed with various treatments. During follow-up (12.2 ±11.3 years), severe manifestations of systemic lupus erythematosus were rare. Antiphospholipid antibodies were repeatedly positive for 90% of the patients. Twelve patients developed arterial thrombosis. Prophylactic treatment with antithrombotic therapy might reduce the risk of further thrombosis (8% versus 57%; P = 0.01). Cardiac valvulopathy occurred in 22 patients during follow-up. Chorea relapsed in 8 cases. Conclusions: Chorea had a good outcome in itself. This long-term follow-up shows, for the first time, that these patients have substantial risk for further arterial thrombosis.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17F</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Syndrome choréique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Chorea</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Corea síndrome</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Lupus érythémateux disséminé</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Systemic lupus erythematosus</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Lupus eritematoso sistémico</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Syndrome des antiphospholipides</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Antiphospholipid antibody syndrome</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Antifosfolípido síndrome</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Thrombose</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Thrombosis</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Trombosis</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Long terme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Long term</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Largo plazo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Pronostic</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Prognosis</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Pronóstico</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Thrombocyte</s0>
<s5>78</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Platelet</s0>
<s5>78</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Trombocito</s0>
<s5>78</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Maladie autoimmune</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Autoimmune disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad autoinmune</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Maladie de système</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Systemic disease</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Enfermedad sistémica</s0>
<s5>44</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Pathologie de la peau</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Skin disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Piel patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Pathologie du tissu conjonctif</s0>
<s5>46</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Connective tissue disease</s0>
<s5>46</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Tejido conjuntivo patología</s0>
<s5>46</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>47</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>47</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>47</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>48</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>48</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>48</s5>
</fC07>
<fC07 i1="12" i2="X" l="FRE"><s0>Hémopathie</s0>
<s5>49</s5>
</fC07>
<fC07 i1="12" i2="X" l="ENG"><s0>Hemopathy</s0>
<s5>49</s5>
</fC07>
<fC07 i1="12" i2="X" l="SPA"><s0>Hemopatía</s0>
<s5>49</s5>
</fC07>
<fC07 i1="13" i2="X" l="FRE"><s0>Pathologie des vaisseaux sanguins</s0>
<s5>50</s5>
</fC07>
<fC07 i1="13" i2="X" l="ENG"><s0>Vascular disease</s0>
<s5>50</s5>
</fC07>
<fC07 i1="13" i2="X" l="SPA"><s0>Vaso sanguíneo patología</s0>
<s5>50</s5>
</fC07>
<fN21><s1>009</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002975 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002975 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Curation |type= RBID |clé= Pascal:12-0026980 |texte= Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies }}
This area was generated with Dilib version V0.6.23. |